KR930012036A - 골 흡수 억제용 약제학적 조성물 - Google Patents

골 흡수 억제용 약제학적 조성물 Download PDF

Info

Publication number
KR930012036A
KR930012036A KR1019920024122A KR920024122A KR930012036A KR 930012036 A KR930012036 A KR 930012036A KR 1019920024122 A KR1019920024122 A KR 1019920024122A KR 920024122 A KR920024122 A KR 920024122A KR 930012036 A KR930012036 A KR 930012036A
Authority
KR
South Korea
Prior art keywords
group
bone resorption
pharmaceutical composition
hydroxyl group
hydrogen atom
Prior art date
Application number
KR1019920024122A
Other languages
English (en)
Other versions
KR100257496B1 (ko
Inventor
미즈호 이나즈
료이치 사토
쓰토무 이노우에
히로시 기타가와
마사카즈 가토
엥글레르트 하인리히
까르니아또 드니
랑 한스-요헨
Original Assignee
원본미기재
훽스트 제팬 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 훽스트 제팬 리미티드 filed Critical 원본미기재
Publication of KR930012036A publication Critical patent/KR930012036A/ko
Application granted granted Critical
Publication of KR100257496B1 publication Critical patent/KR100257496B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 약제학적 담체 및 치료적 유효량의 일반식(I)의 벤조피란 유도체를 포함하는, 골 흡수 억제용 약제학적 조성물에 관한 것이다.
상기식에서, 점선 결합은 임의의 이중결합이고, R1은 수소 원자 또는 하이드록실 그룹이며, R2는 시아노 그룹, 페닐설포닐 그룹 또는 할로겐 치환된 메톡실 그룹이고, R3은 구조식
의 그룹이다.
당해 조성물은 골 흡수를 억제하므로, 골 물질 대사 관련 질병의 치료 및 예방에 유용하다.

Description

골 흡수 억제용 약제학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 약제학적 담체 및 치료적 유효량의 일반식(I)의 벤조피란 유도체를 포함하는, 골 흡수 억제용 약제학적 조성물.
    상기식에서, 점선 결합은 임의의 이중결합이고, R1은 수소원자 또는 하이드록실 그룹이며, R2는 시아노 그룹, 페닐설포닐 그룹 또는 할로겐 치환된 메톡실 그룹이고, R3은 구조식
    의 그룹이다.
  2. 제1항에 있어서, R1이 하이드록실 그룹이고 R2가 시아노 그룹이며 R3이 R1에 대해 트란스위치로 존재하는 2-옥소-1-피롤리디닐 그룹이고 점선 결합이 단일결합인 약제학적 조성물.
  3. 제1항에 있어서, R1이 하이드록실 그룹이고 R2가 페닐설포닐 그룹이며 R3이 R1에 대해 트란스 위치로 존재하는 2-옥소-1-피롤리디닐 그룹이고 점선 결합이 단일결합인 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019920024122A 1991-12-16 1992-12-14 골 흡수 억제용 약제학적 조성물 KR100257496B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP33176791 1991-12-16
JP91-331,767 1991-12-16
JP92-239,144 1992-09-08
JP23914492A JP3502403B2 (ja) 1991-12-16 1992-09-08 骨吸収抑制剤

Publications (2)

Publication Number Publication Date
KR930012036A true KR930012036A (ko) 1993-07-20
KR100257496B1 KR100257496B1 (ko) 2000-08-01

Family

ID=26534099

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920024122A KR100257496B1 (ko) 1991-12-16 1992-12-14 골 흡수 억제용 약제학적 조성물

Country Status (10)

Country Link
US (1) US5317029A (ko)
EP (1) EP0547545B1 (ko)
JP (1) JP3502403B2 (ko)
KR (1) KR100257496B1 (ko)
AT (1) ATE114465T1 (ko)
CA (1) CA2085421A1 (ko)
DE (1) DE69200757T2 (ko)
DK (1) DK0547545T3 (ko)
ES (1) ES2066546T3 (ko)
TW (1) TW223016B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
US5389646A (en) * 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
GB9408577D0 (en) * 1994-04-29 1994-06-22 Fujisawa Pharmaceutical Co New compound
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
EP0783888A1 (en) * 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
KR100389127B1 (ko) * 2000-10-09 2003-06-25 동부한농화학 주식회사 벤조피라닐 헤테로고리 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물
TWI396543B (zh) 2005-05-12 2013-05-21 Sankyo Co 取代丙烯醯胺衍生物及含有它之醫藥組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
EP0091748B1 (en) * 1982-04-08 1986-06-18 Beecham Group Plc Antihypertensive benzopyranols
EP0093535B1 (en) * 1982-04-28 1986-12-30 Beecham Group Plc Novel chromenes and chromans
JPS58219183A (ja) * 1982-04-28 1983-12-20 ビ−チヤム・グル−プ・ピ−エルシ− 新規なクロマノ−ル，その製法及びそれらを含む製薬組成物
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate

Also Published As

Publication number Publication date
JPH05221860A (ja) 1993-08-31
DE69200757D1 (de) 1995-01-12
DK0547545T3 (da) 1995-05-15
ATE114465T1 (de) 1994-12-15
DE69200757T2 (de) 1995-05-11
US5317029A (en) 1994-05-31
TW223016B (ko) 1994-05-01
ES2066546T3 (es) 1995-03-01
KR100257496B1 (ko) 2000-08-01
CA2085421A1 (en) 1993-06-17
EP0547545A1 (en) 1993-06-23
EP0547545B1 (en) 1994-11-30
JP3502403B2 (ja) 2004-03-02

Similar Documents

Publication Publication Date Title
KR930012036A (ko) 골 흡수 억제용 약제학적 조성물
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
PL326025A1 (en) Substituted imidazoles
KR960700045A (ko) 혈관신생 저해제 및 신규 화합물
KR950010893A (ko) 자궁내막증 억제 방법
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
KR950016726A (ko) 기능부전성 자궁 출혈을 억제하는 방법
KR950010889A (ko) 혈관형성 및 혈관형성성 질병을 억제하는 방법
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR950016727A (ko) 트롬보모듈린 발현을 증가시키는 방법
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
KR910004191A (ko) 신질환치료제
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR950016735A (ko) 터너 증후군의 억제 방법
NO940777L (no) Anvendelse av et pregnanderivat
KR890014536A (ko) 축합 퀴놀린계 화합물, 축합 아크리딘계 화합물 및 그의 제조방법과 그것을 함유하는 항암제 조성물
KR910004557A (ko) 2,4,6-치환 페놀 유도체
DK0593520T3 (da) Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom
ES2163487T3 (es) Conjugados de hirudina a partir de hirudina y compuestos lipofilos.
KR900016144A (ko) 4-이미다졸린 유도체
KR970705387A (ko) 자궁내막암의 억제 방법(methods of inhibiting endometrial cancer)
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
KR970706000A (ko) 자궁내막 유사분열의 저해 방법(methods of inihibiting endometrial mitoses)
KR970704463A (ko) 스트렙토그라민 유도체, 이의 제조 방법 및 이를 함유하는 약학 조성물(streptogramine derivatives, preparation of same and pharmaceutical compositions containing same)
KR920008012A (ko) 트리아졸 유도체

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee